Do hemangioendotheliomas originate primarily in bone or in soft tissue (extramedullary structures)?

Hemangioendothelioma Origin: Bone vs Soft Tissue

Hemangioendotheliomas can originate in both bone and soft tissue (extramedullary structures), though soft tissue origin is more common. 1, 2

Primary Sites of Origin

Vascular Tissue as the Source

• Hemangioendotheliomas arise from vascular tissue, which can be present in both bone and soft tissue locations 1
• The NCCN explicitly states that "vascular tissue gives rise to hemangioendothelioma and hemangiopericytoma" when discussing bone cancers, confirming bone as a recognized primary site 1

Soft Tissue as Primary Site

• Hemangioendotheliomas most commonly originate from soft tissues and visceral organs 3, 4, 2
• Cutaneous and subcutaneous soft tissue involvement represents the majority of cases 4, 2, 5
• These tumors show "borderline biological behavior, intermediate between entirely benign hemangiomas and highly malignant angiosarcomas" 2

Bone as Primary Site

• Primary bone hemangioendotheliomas are extremely rare but well-documented 3, 6
• Epithelioid hemangioendothelioma of bone is "rarely encountered" and represents a low-grade malignant tumor 6
• Spinal involvement is particularly uncommon, with only five reported cases in one literature review 3
• When bone involvement occurs, it can affect long bones (metatarsals, tibia) and vertebrae 3, 6

Clinical Implications

Distinguishing from Infantile Hemangiomas

• Do not confuse hemangioendotheliomas with infantile hemangiomas, which are entirely different entities 7, 8, 9
• Infantile hemangiomas are benign vascular tumors of infancy appearing in the first weeks of life with characteristic proliferation and involution phases 7, 8
• Hemangioendotheliomas are intermediate-grade vascular neoplasms with malignant potential, occurring across all age groups 2

Multisystem Evaluation Required

• When hemangioendothelioma is diagnosed in any location, complete systemic assessment is mandatory to exclude multifocal disease 4, 6
• Scintigraphic examination may reveal additional skeletal lesions not apparent on plain radiographs 6
• The disease has "an indolent course, with the potential for recurrence and often associated with multi-systemic localizations" 4

Treatment Approach

• Wide surgical excision is the mainstay of therapy regardless of primary site 4, 6
• For bone lesions, this may require en bloc resection with reconstruction 6
• Regular long-term follow-up is essential due to recurrence potential and low metastatic risk, primarily to regional lymph nodes 4, 2